Sandoz Group AG ADR (D8Y0)
XDUS 
Summary
D8Y0 Chart
Generic drugmaker Sandoz to engage with US after Trump tariff threat
Swiss generic drugmaker Sandoz said on Wednesday it would continue discussions with policymakers after U.S. President Donald Trump threatened the industry with steep tariffs unless drugmakers manufacture medicines domestically.
FDA set to review Sandoz's generic GLP-1s
The U.S. Food and Drug Administration has agreed to review Swiss generics drugmaker Sandoz's two generic tirzepatide GLP-1s that, if approved, would rival obesity drugs made by Eli Lilly.
3 Generic Drug Stocks to Watch as New Growth Drivers Emerge
Sandoz, Teva and Viatris target biosimilars, complex generics and specialty drugs as new growth drivers reshape the Medical - Generic Drugs industry.
Sandoz Group AG ADR (D8Y0) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Sandoz Group AG ADR ever had a stock split?
Sandoz Group AG ADR Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Richard Saynor CEO | XDUS Exchange | US7999261008 ISIN |
| CH Country | 23,000 Employees | 14 Apr 2026 Last Dividend | - Last Split | - IPO Date |
Overview
Sandoz Group AG is a global leader in the development, manufacture, and marketing of generic pharmaceuticals and biosimilars. Established in 1886, the company has its headquarters in Basel, Switzerland. Sandoz operates globally, offering a wide range of therapeutic solutions aimed at improving patient outcomes. Its mission revolves around making high-quality medicines accessible to people worldwide, leveraging its extensive experience and innovation in the pharmaceutical sector.
Products and Services
- Cardiovascular - Sandoz offers a comprehensive range of products for treating cardiovascular diseases, aiming to improve heart health and patient quality of life.
- Central Nervous System - The company provides generic treatments for central nervous system disorders, focusing on medications that help manage conditions such as epilepsy and multiple sclerosis.
- Oncology - Sandoz supports cancer treatment with generic drugs and biosimilars, designed to be more accessible options for patients undergoing oncologic therapies.
- Infectious Diseases - They have a broad portfolio of antibiotics and antiviral medicines to treat various infectious diseases, contributing to global efforts in combating antimicrobial resistance.
- Pain and Respiratory - The company develops medications for managing pain and respiratory conditions, helping individuals lead more comfortable lives.
- Diabetes - Sandoz provides treatments for diabetes, focusing on improving the lives of those living with this chronic condition through more affordable therapeutic options.
- Immunology, Endocrinology, Hematology - Products in these categories include treatments for autoimmune diseases, hormonal disorders, and blood conditions, addressing a range of complex health issues.
- Ophthalmology - Sandoz also offers treatments for eye diseases, supporting vision health and preventing blindness.
- Bone Disease - The company has treatments for bone diseases, focusing on medications that help improve bone density and reduce fracture risk.
- Active Pharmaceutical Ingredients and Finished Dosage Forms - Sandoz supplies a wide range of active ingredients and finished pharmaceutical products, catering to both the manufacturing needs of the industry and the direct treatment needs of patients.
